Norges Bank’s Cidara Therapeutics CDTX Stock Holding History

Norges Bank’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-200,000	Closed	-$44.2M	–	261
2025 Q4	$44.2M	Buy	+200,000	New	+$32.3M	﹤0.01%	1064
2015 Q3	–	Sell	-500	Closed	-$140K	–	2289
2015 Q2	$140K	Buy	+500	New	+$154K	﹤0.01%	2238

Norges Bank's CDTX Position: Q1 2026 in Review

Norges Bank sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 200,000 shares — an estimated $44.2M sold.

Norges Bank first reported a position in CDTX in Q2 2015 and held it in 2 quarters. The position peaked at $44.2M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Norges Bank reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 200,000 Cidara Therapeutics shares in Q1 2026, an estimated $44.2M.
Norges Bank first reported a position in Cidara Therapeutics in Q2 2015 and held it in 2 quarters.
Norges Bank's Cidara Therapeutics position peaked at $44.2M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.